What is Retatrutide
Retatrutide is a next-generation research peptide designed to activate GLP-1, GIP, and glucagon receptors simultaneously for comprehensive metabolic study.
Potential Research Effects
• Accelerated weight reduction through multi-pathway signaling
• Improved glucose and lipid metabolism
• Enhanced thermogenesis and energy utilization
• Research interest in long-term metabolic modulation
Includes 10 sterile research-use syringes with every vial order.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes.
These materials are supplied for in-vitro research only (“in glass”) and are
not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have
not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency.
They are not intended to diagnose, treat, cure, or prevent any disease.
Any form of bodily introduction, clinical testing, or therapeutic application is strictly prohibited.
